|
陸、 參考文獻
Adams, J. M. and Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-6.
Albrechtsen, N., Dornreiter, I., Grosse, F., Kim, E., Wiesmuller, L. and Deppert, W. (1999) Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 18, 7706-17.
Almog, N. and Rotter, V. (1997) Involvement of p53 in cell differentiation and development. Biochim. Biophys. Act. 1333, F1-27.
Aoki, N., Yamaguchi-Aoki, Y. and Ullrich, A. (1996) The novel protein-tyrosine phosphatase PTP20 is a positive regulator of PC12 cell neuronal differentiation. J. Biol. Chem. 271, 29422-6.
Armstrong, J. F., Kaufman, M. H., Harrison, D. J. and Clarke, A. R. (1995) High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5, 931-6.
Babior, B. M. (1990) Hematology: apathophysiological approach.
Bakalkin, G., Selivanova, G., Yakovleva, T., Kiseleva, E., Kashuba, E., Magnusson, K. P., Szekely, L., Klein, G., Terenius, L. and Wiman, K. G. (1995) p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res. 23, 362-9.
Bakalkin, G., Yakovleva, T., Selivanova, G., Magnusson, K. P., Szekely, L., Kiseleva, E., Klein, G., Terenius, L. and Wiman, K. G. (1994) p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA 91, 413-7.
Baldassarre, G., Barone, M. V., Belletti, B., Sandomenico, C., Bruni, P., Spiezia, S., Boccia, A., Vento, M. T., Romano, A., Pepe, S., Fusco, A. and Viglietto, G. (1999) Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 18, 6241-51.
Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y. and Ziv, Y. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-7.
Bates, S. and Vousden, K. H. (1999) Mechanisms of p53-mediated apoptosis. Cell Mol. Life. Sci. 55, 28-37.
Baudier, J., Delphin, C., Grunwald, D., Khochbin, S. and Lawrence, J. J. (1992) Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. USA 89, 11627-31.
Bayle, J. H., Elenbaas, B. and Levine, A. J. (1995) The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc. Natl. Acad. Sci. USA. 92, 5729-33.
Ben-David, Y. and Bernstein, A. (1991) Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66, 831-4.
Ben-David, Y., Lavigueur, A., Cheong, G. Y. and Bernstein, A. (1990) Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes. New Biol. 2, 1015-23.
Beru, N., Maples, P. B., Hermine, O. and Goldwasser, E. (1990). Differential expression of alpha- and beta-globin genes in erythroleukemic cell lines. Mol. Cell Biol. 10, 3591-5.
Bischoff, J. R., Friedman, P. N., Marshak, D. R., Prives, C. and Beach, D. (1990) Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA 87, 4766-70.
Bissonnette, N., Wasylyk, B. and Hunting, D. J. (1997) The apoptotic and transcriptional transactivation activities of p53 can be dissociated. Biochem. Cell Biol. 75, 351-8.
Booher, R. N., Holman, P. S. and Fattaey, A. (1997) Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272, 22300-6.
Brady, H. J., Salomons, G. S., Bobeldijk, R. C. and Berns, A. J. (1996) T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. gene product in. EMBO J. 15, 1221-30.
Brain, R. and Jenkins, J. R. (1994) Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP. Oncogene 9, 1775-80.
Bratton, S. B., MacFarlane, M., Cain, K. and Cohen, G. M. (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp. Cell Res. 256, 27-33.
Brown, J. P., Wei, W. and Sedivy, J. M. (1997) Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831-4.
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T. and Hannon, G. J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-7.
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R. and Kley, N. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-9.
Budihardjo, I., Oliver, H., Lutter, M., Luo, X. and Wang, X. (1999) Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell. Dev. Biol. 15, 269-90.
Burand, J. P. and Lu, H. (1997) Replication of a Gonad-Specific Insect Virus in TN-368 Cells in Culture. J. Invertebr. Pathol. 70, 88-95.
Burma, S., Kurimasa, A., Xie, G., Taya, Y., Araki, R., Abe, M., Crissman, H. A., Ouyang, H., Li, G. C. and Chen, D. J. (1999) DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. J. Biol. Chem. 274, 17139-43.
Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-3.
Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B. and Siliciano, J. D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-9.
Carr, A. M. (2000) Cell cycle. Piecing together the p53 puzzle. Science 287, 1765-6.
Casaccia-Bonnefil, P., Tikoo, R., Kiyokawa, H., Friedrich, V., Jr., Chao, M. V. and Koff, A. (1997) Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev. 11, 2335-46.
Caspari, T. (2000) How to activate p53. Curr. Biol. 10, R315-7.
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. and Vogelstein, B. (1999) 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616-20.
Chaturvedi, P., Eng, W. K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., Scott, G. F., Li, X., Carr, S. A., Johnson, R. K., Winkler, J. D. and Zhou, B. B. (1999) Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047-54.
Chehab, N. H., Malikzay, A., Appel, M. and Halazonetis, T. D. (2000) Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14, 278-88.
Chehab, N. H., Malikzay, A., Stavridi, E. S. and Halazonetis, T. D. (1999) Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA 96, 13777-82.
Chen, X., Ko, L. J., Jayaraman, L. and Prives, C. (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2438-51.
Cho, Y., Gorina, S., Jeffrey, P. D. and Pavletich, N. P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-55.
Choppin, J., Lacombe, C., Casadevall, N., Muller, O., Tambourin, P. and Varet, B. (1984) Characterization of erythropoietin produced by IW32 murine erythroleukemia cells. Blood 64, 341-7.
Chow, V., Ben-David, Y., Bernstein, A., Benchimol, S. and Mowat, M. (1987) Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J Virol. 61, 2777-81.
Chylicki, K., Ehinger, M., Svedberg, H. and Gullberg, U. (2000) Characterization of the molecular mechanisms for p53-mediated differentiation. Cell Growth Differ. 11, 561-71.
Clarke, M. F., Kukowska-Latallo, J. F., Westin, E., Smith, M. and Prochownik, E. V. (1988) Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8, 884-92.
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H. and Reid, B. J. (1995) A p53-dependent mouse spindle checkpoint. Science 267, 1353-6.
Crossley, M. and Orkin, S. H. (1993) Regulation of the beta-globin locus. Curr. Opin. Genet. Dev. 3, 232-7.
Deng, C., Zhang, P., Harper, J. W., Elledge, S. J. and Leder, P. (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-84.
Donehower, L. A. (1996) The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7, 269-78.
Dotto, G. P. (2000). p21(WAF1/Cip1) more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43-56.
Dragovich, T., Rudin, C. M. and Thompson, C. B. (1998) Signal transduction pathways that regulate cell survival and cell death. Oncogene 17, 3207-13.
Dumaz, N. and Meek, D. W. (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18, 7002-10.
Durand, B., Gao, F. B. and Raff, M. (1997) Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16, 306-17.
Ehinger, M., Bergh, G., Johnsson, E., Baldetorp, B., Olsson, I. and Gullberg, U. (1998) p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control. Exp. Hematol. 26, 1043-52.
Ehinger, M., Bergh, G., Johnsson, E., Gullberg, U. and Olsson, I. (1997) The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein. Cell Growth Differ. 8, 1127-37.
Eizenberg, O., Faber-Elman, A., Gottlieb, E., Oren, M., Rotter, V. and Schwartz, M. (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol. 16, 5178-85.
el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-25.
Elledge, S. J. (1996) Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-72.
Eymin, B., Haugg, M., Droin, N., Sordet, O., Dimanche-Boitrel, M. T. and Solary, E. (1999) p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene 18, 1411-8.
Feinstein, E., Gale, R. P., Reed, J. and Canaani, E. (1992) Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 7, 1853-7.
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K. and Roberts, J. M. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733-44.
Finucane, D. M., Bossy-Wetzel, E., Waterhouse, N. J., Cotter, T. G. and Green, D. R. (1999) Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274, 2225-33.
Finucane, D. M., Bossy-Wetzel, E., Waterhouse, N. J., Cotter, T. G. and Green, D. R. (1999) Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274, 2225-33.
Friedlander, P., Haupt, Y., Prives, C. and Oren, M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16, 4961-71.
Friedman, S. L., Shaulian, E., Littlewood, T., Resnitzky, D. and Oren, M. (1997) Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Oncogene 15, 63-70.
Fu, L. and Benchimol, S. (1997) Participation of the human p53 3''UTR in translational repression and activation following gamma-irradiation. EMBO J. 16, 4117-25.
Fujita, H., Yamamoto, M., Yamagami, T., Hayashi, N. and Sassa, S. (1991) Erythroleukemia differentiation. Distinctive responses of the erythroid-specific and the nonspecific delta-aminolevulinate synthase mRNA. J. Biol. Chem. 266, 17494-502.
Fujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C. and Orkin, S. H. (1996) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 93, 12355-8.
Furnari, B., Rhind, N. and Russell, P. (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277, 1495-7.
Gervais, J. L., Seth, P. and Zhang, H. (1998) Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273, 19207-12.
Ghebranious, N. and Donehower, L. A. (1998) Mouse models in tumor suppression. Oncogene 17, 3385-400.
Giaccia, A. J. and Kastan, M. B. (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-83.
Gil-Gomez, G., Berns, A. and Brady, H. J. (1998) A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17, 7209-18.
Girard, F., Strausfeld, U., Fernandez, A. and Lamb, N. J. (1991) Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 1169-79.
Godin, I. E., Garcia-Porrero, J. A., Coutinho, A., Dieterlen-Lievre, F. and Marcos, M. A. (1993) Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364, 67-70.
Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. C. and Holbrook, N. J. (1997) p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14, 929-35.
Gorospe, M., Wang, X., Guyton, K. Z. and Holbrook, N. J. (1996) Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol. 16, 6654-60.
Gottlieb, E. and Oren, M. (1998) p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J. 17, 3587-96.
Gottlieb, T. M. and Oren, M. (1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta. 1287, 77-102.
Gross, A., Jockel, J., Wei, M. C. and Korsmeyer, S. J. (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878-85.
Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999a) BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-911.
Gross, A., Yin, X. M., Wang, K., Wei, M. C., Jockel, J., Milliman, C., Erdjument-Bromage, H., Tempst, P. and Korsmeyer, S. J. (1999b) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274, 1156-63.
Gu, W. and Roeder, R. G. (1997a) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
Gu, W., Shi, X. L. and Roeder, R. G. (1997b) Synergistic activation of transcription by CBP and p53. Nature 387, 819-23.
Guillouf, C., Rosselli, F., Sjin, R. T., Moustacchi, E., Hoffman, B. and Liebermann, D. A. (1998) Role of a mutant p53 protein in apoptosis: characterization of a function independent of transcriptional trans-activation. Int. J. Oncol. 13, 107-14.
Hakem, A., Sasaki, T., Kozieradzki, I. and Penninger, J. M. (1999) The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. J. Exp. Med. 189, 957-68.
Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D. and Lassar, A. B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-21.
Han, Z., Bhalla, K., Pantazis, P., Hendrickson, E. A. and Wyche, J. H. (1999) Cif (Cytochrome c efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid. Mol. Cell. Biol. 19, 1381-9.
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-16.
Haupt, Y., Rowan, S. and Oren, M. (1995) p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10, 1563-71.
Heath, D. S., Axelrad, A. A., McLeod, D. L. and Shreeve, M. M. (1976) Separation of the erythropoietin-responsive progenitors BFU-E and CFU-E in mouse bone marrow by unit gravity sedimentation. Blood 47, 777-92.
Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W. and Vogelstein, B. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11.
Herrmann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W. and Kalden, J. R. (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22, 5506-7.
Hirao, A., Kong, Y. Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J. and Mak, T. W. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-7.
Hirao, A., Kong, Y. Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J. and Mak, T. W. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-7.
Hiromura, K., Pippin, J. W., Fero, M. L., Roberts, J. M. and Shankland, S. J. (1999) Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J. Clin. Invest. 103, 597-604.
Hiromura, K., Pippin, J. W., Fero, M. L., Roberts, J. M. and Shankland, S. J. (1999) Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J. Clin. Invest. 103, 597-604.
Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. and Harris, C. C. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-5.
Horikoshi, N., Usheva, A., Chen, J., Levine, A. J., Weinmann, R. and Shenk, T. (1995) Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol. Cell. Biol. 15, 227-34.
Hu, Y., Benedict, M. A., Wu, D., Inohara, N. and Nunez, G. (1998) Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA 95, 4386-91.
Hupp, T. R., Meek, D. W., Midgley, C. A. and Lane, D. P. (1993) Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21, 3167-74.
Hupp, T. R., Sparks, A. and Lane, D. P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-45.
Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E. and Fisher, P. B. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9, 3397-406.
Jin, Y. H., Yoo, K. J., Lee, Y. H. and Lee, S. K. (2000) Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J. Biol. Chem. 275, 30256-63.
Johnson, D. G. and Walker, C. L. (1999) Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312.
Johnson, P., Chung, S. and Benchimol, S. (1993) Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13, 1456-63.
Kapoor, M. and Lozano, G. (1998) Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl. Acad. Sci. USA 95, 2834-7.
Kastan, M. B., Stone, K. D. and Civin, C. I. (1989) Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. Blood 74, 1517-24.
Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B. and Fornace, A. J., Jr. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-97.
Kelekar, A., Chang, B. S., Harlan, J. E., Fesik, S. W. and Thompson, C. B. (1997) Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol. 17, 7040-6.
Kitada, S., Krajewski, S., Miyashita, T., Krajewska, M. and Reed, J. C. (1996) Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12, 187-92.
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A. and Koff, A. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-32.
Kluck, R. M., Bossy-Wetzel, E., Green, D. R. and Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-6.
Kluck, R. M., Bossy-Wetzel, E., Green, D. R. and Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-6.
Knudson, C. M., Tung, K. S., Tourtellotte, W. G., Brown, G. A. and Korsmeyer, S. J. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-9.
Ko, L. J. and Prives, C. (1996).p53: puzzle and paradigm. Genes Dev. 10, 1054-72.
Ko, L. J., Shieh, S. Y., Chen, X., Jayaraman, L., Tamai, K., Taya, Y., Prives, C. and Pan, Z. Q. (1997) p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol. Cell. Biol. 17, 7220-9.
Kranenburg, O., de Groot, R. P., Van der Eb, A. J. and Zantema, A. (1995) Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene 10, 87-95.
Kroemer, G., Dallaporta, B. and Resche-Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-42.
Kume, T., Tsuneizumi, K., Watanabe, T., Thomas, M. L. and Oishi, M. (1994) Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse erythroleukemia cells. J. Biol. Chem. 269, 4709-12.
Kume, T., Watanabe, T., Sanokawo, R., Chida, D., Nakamura, T. and Oishi, M (1996). Expression of the protein tyrosine phosphatase beta2 gene in mouse erythroleukemia cells induces terminal erythroid differentiation. J. Biol. Chem. 271, 30916-21.
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R. and Brady, J. N (1998). Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem. 273, 33048-53.
LaMontagne, K. R., Jr., Flint, A. J., Franza, B. R., Jr., Pandergast, A. M. and Tonks, N. K. (1998a) Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo. Mol. Cell. Biol. 18, 2965-75.
LaMontagne, K. R., Jr., Hannon, G. and Tonks, N. K. (1998b) Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. Proc. Natl. Acad. Sci. USA 95, 14094-9.
Laronga, C., Yang, H. Y., Neal, C. and Lee, M. H. (2000) Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J. Biol. Chem. 275, 23106-12.
Lee, M. H., Reynisdottir, I. and Massague, J. (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-49.
Lee, S., Cavallo, L. and Griffith, J. (1997) Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272, 7532-9.
Lee, S., Elenbaas, B., Levine, A. and Griffith, J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013-20.
Lees-Miller, S. P., Chen, Y. R. and Anderson, C. W. (1990) Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell. Biol. 10, 6472-81.
Leveillard, T., Andera, L., Bissonnette, N., Schaeffer, L., Bracco, L., Egly, J. M. and Wasylyk, B. (1996) Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 15, 1615-24.
Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-31.
Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M. and Ross, R. (1998) Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell 1, 553-63.
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S. and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-89.
Li, P. F., Dietz, R. and von Harsdorf, R. (1999) p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18, 6027-36.
Lin, J., Chen, J., Elenbaas, B. and Levine, A. J. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235-46.
Lin, Y., Ma, W. and Benchimol, S. (2000) Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26, 122-7.
Liu, F., Stanton, J. J., Wu, Z. and Piwnica-Worms, H. (1997) The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17, 571-83.
Liu, M., Lee, M. H., Cohen, M., Bommakanti, M. and Freedman, L. P. (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-53.
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T. D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-35.
Lozano, G. and Liu, G. (1998) Mouse models dissect the role of p53 in cancer and development. Semin. Cancer Biol. 8, 337-44.
Lu, H. and Levine, A. J. (1995) Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92, 5154-8.
Lu, H., Taya, Y., Ikeda, M. and Levine, A. J. (1998) Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc. Natl. Acad. Sci. USA 95, 6399-402.
Matsuoka, S., Huang, M. and Elledge, S. J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-7.
Mazzaro, G., Bossi, G., Coen, S., Sacchi, A. and Soddu, S. (1999) The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells. Oncogene 18, 5831-5.
Meikrantz, W. and Schlegel, R. (1996) Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem. 271, 10205-9.
Michalovitz, D., Halevy, O. and Oren, M. (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62, 671-80.
Milne, D. M., Palmer, R. H., Campbell, D. G. and Meek, D. W. (1992) Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene 7, 1361-9.
Miyashita, T., Harigai, M., Hanada, M. and Reed, J. C. (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54, 3131-5.
Miyashita, T. and Reed, J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-9.
Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F. and Deppert, W. (1995) Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14, 4442-9.
Muller-Tiemann, B. F., Halazonetis, T. D. and Elting, J. J. (1998) Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. Proc. Natl. Acad. Sci. USA 95, 6079-84.
Murphy, M., Hinman, A. and Levine, A. J. (1996) Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10, 2971-80.
Nakano, K. and Vousden, K. H. (2001) PUMA, a novel proapoptotic gene is induced by p53. Mol. Cell 7, 683-94.
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I. and Loh, D. Y. (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-20.
Nasmyth, K. (1996) Viewpoint: putting the cell cycle in order. Science 274, 1643-5.
Niculescu, A. B., 3rd, Chen, X., Smeets, M., Hengst, L., Prives, C. and Reed, S. I. (1998) Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629-43.
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M. and Smith, J. R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-8.
Nuez, B., Michalovich, D., Bygrave, A., Ploemacher, R. and Grosveld, F. (1995) Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375, 316-8.
O''Connell, M. J., Walworth, N. C. and Carr, A. M. (2000 The G2-phase DNA-damage checkpoint. Trends Cell Biol. 10, 296-303
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T. and Tanaka, N. (2000a) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-8.
Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y. and Taya, Y. (2000b) p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102, 849-62.
Offerhaus, G. J., Giardiello, F. M., Bruijn, J. A., Stijnen, T., Molyvas, E. N. and Fleuren, G. J. (1991) The value of immunohistochemistry for collagen IV expression in colorectal carcinomas. Cancer 67, 99-105.
Ohki, R., Nemoto, J., Murasawa, H., Oda, E., Inazawa, J., Tanaka, N. and Taniguchi, T. (2000) Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J. Biol. Chem. 275, 22627-30.
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M. and Pagano, M. (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15, 2612-24.
Orkin, S. H. (1992) GATA-binding transcription factors in hematopoietic cells. Blood 80, 575-81.
Orkin, S. H. (1995) Transcription factors and hematopoietic development. J. Biol. Chem. 270, 4955-8.
Ottilie, S., Diaz, J. L., Horne, W., Chang, J., Wang, Y., Wilson, G., Chang, S., Weeks, S., Fritz, L. C. and Oltersdorf, T. (1997) Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem. 272, 30866-72.
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W. W., Kruzel, E. and et al. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15, 3032-40.
Pan, G., O''Rourke, K. and Dixit, V. M. (1998) Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273, 5841-5.
Park, D. S., Farinelli, S. E. and Greene, L. A. (1996) Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271, 8161-9.
Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W. and Elledge, S. J. (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-7.
Peng, C. Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S. and Piwnica-Worms, H. (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-5.
Perkins, A. C., Sharpe, A. H. and Orkin, S. H. (1995) Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375, 318-22.
Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S. F., D''Agati, V., Orkin, S. H. and Costantini, F. (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-60.
Poluha, W., Poluha, D. K., Chang, B., Crosbie, N. E., Schonhoff, C. M., Kilpatrick, D. L. and Ross, A. H. (1996) The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16, 1335-41.
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389, 300-5.
Ponka, P. (1997) Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89, 1-25.
Price, B. D., Hughes-Davies, L. and Park, S. J. (1995) Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene 11, 73-80.
Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A. and Baserga, R. (1997) The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol. 17, 1084-92.
Prives, C. (1998) Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8.
Profous-Juchelka, H. R., Reuben, R. C., Marks, P. A. and Rifkind, R. A. (1983) Transcriptional and post-transcriptional regulation of globin gene accumulation in murine erythroleukemia cells. Mol. Cell. Biol. 3, 229-32.
Rajah, R., Valentinis, B. and Cohen, P. (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272, 12181-8.
Reed, M., Woelker, B., Wang, P., Wang, Y., Anderson, M. E. and Tegtmeyer, P. (1995) The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92, 9455-9.
Reynaud, E. G., Leibovitch, M. P., Tintignac, L. A., Pelpel, K., Guillier, M. and Leibovitch, S. A. (2000) Stabilization of MyoD by direct binding to p57(Kip2). J. Biol. Chem. 275, 18767-76.
Riddle, R. D., Yamamoto, M. and Engel, J. D. (1989) Expression of delta-aminolevulinate synthase in avian cells: separate genes encode erythroid-specific and nonspecific isozymes. Proc. Natl. Acad. Sci. USA 86, 792-6.
Robertson, J. D., Orrenius, S. and Zhivotovsky, B. (2000) Review: nuclear events in apoptosis. J. Struct. Biol. 129, 346-58.
Romana, M., Dubart, A., Beaupain, D., Chabret, C., Goossens, M. and Romeo, P. H. (1987) Structure of the gene for human uroporphyrinogen decarboxylase. Nucleic Acids Res. 15, 7343-56.
Ronen, D., Schwartz, D., Teitz, Y., Goldfinger, N. and Rotter, V. (1996) Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ. 7, 21-30.
Rotter, V., Schwartz, D., Almon, E., Goldfinger, N., Kapon, A., Meshorer, A., Donehower, L. A. and Levine, A. J. (1993) Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc. Natl. Acad. Sci. USA 90, 9075-9.
Sabbatini, P., Chiou, S. K., Rao, L. and White, E. (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15, 1060-70.
Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T. and Jacks, T. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet.10, 175-80.
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W. and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-41.
Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E. and Xie, D. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-24.
Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E. and Xie, D. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-24.
Schlesinger, P. H., Gross, A., Yin, X. M., Yamamoto, K., Saito, M., Waksman, G. and Korsmeyer, S. J. (1997) Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94, 11357-62.
Schmidt, T., Korner, K., Karsunky, H., Korsmeyer, S., Muller, R. and Moroy, T. (1999) The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53. Cell Death Differ. 6, 873-82.
Schneider, E., Montenarh, M. and Wagner, P. (1998) Regulation of CAK kinase activity by p53. Oncogene 17, 2733-41.
Sgambato, A., Cittadini, A., Faraglia, B. and Weinstein, I. B. (2000) Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J. Cell Physiol. 183, 18-27.
Shaulsky, G., Goldfinger, N., Peled, A. and Rotter, V. (1991) Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 88, 8982-6.
Sherr, C. J. (1994) G1 phase progression: cycling on cue. Cell 79, 551-5.
Sherr, C. J. and Roberts, J. M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-12.
Sherr, C. J. and Roberts, J. M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-63.
Sherr, C. J. and Weber, J. D. (2000) The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94-9.
Shi, L., Chen, G., He, D., Bosc, D. G., Litchfield, D. W. and Greenberg, A. H. (1996 Granzyme B induces apoptosis and cyclin A-associated cyclin-dependent kinase activity in all stages of the cell cycle. J. Immunol. 157, 2381-5.
Shiah, S. G., Chuang, S. E., Chau, Y. P., Shen, S. C. and Kuo, M. L. (1999) Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. Cancer Res. 59, 391-8.
Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y. and Prives, C. (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289-300.
Shieh, S. Y., Ikeda, M., Taya, Y. and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-34.
Shieh, S. Y., Taya, Y. and Prives, C. (1999) DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18, 1815-23.
Shimizu, A., Nishida, J., Ueoka, Y., Kato, K., Hachiya, T., Kuriaki, Y. and Wake, N. (1998) CyclinG contributes to G2/M arrest of cells in response to DNA damage. Biochem. Biophys. Res. Commun. 242, 529-33.
Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H. and Tsujimoto, Y. (1996) Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21-9.
Shivakumar, C. V., Brown, D. R., Deb, S. and Deb, S. P. (1995) Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol. Cell. Biol. 15, 6785-93.
Shivdasani, R. A. and Orkin, S. H. (1996) The transcriptional control of hematopoiesis. Blood 87, 4025-39.
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E. and Kastan, M. B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471-81.
Sionov, R. V. and Haupt, Y. (1999) The cellular response to p53: the decision between life and death. Oncogene 18, 6145-57.
Skapek, S. X., Rhee, J., Spicer, D. B. and Lassar, A. B. (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267, 1022-4.
Slingerland, J. and Pagano, M. (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183, 10-7.
Smith, M. L., Chen, I. T., Zhan, Q., Bae, I., Chen, C. Y., Gilmer, T. M., Kastan, M. B., O''Connor, P. M. and Fornace, A. J., Jr. (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266, 1376-80.
Smits, V. A., Klompmaker, R., Vallenius, T., Rijksen, G., Makela, T. P. and Medema, R. H. (2000) p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J. Biol. Chem. 275, 30638-43.
Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A. and el-Houseini, M. E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9, 3389-96.
Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-9.
Stevens, M. L. Fundamentals of clinical hematology. (1997)
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J. and Wahl, G. M. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-72.
Strasser, A., O''Connor, L. and Dixit, V. M. (2000) Apoptosis signaling. Annu. Rev. Biochem. 69, 217-45.
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M. and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-6.
Takao, N., Kato, H., Mori, R., Morrison, C., Sonada, E., Sun, X., Shimizu, H., Yoshioka, K., Takeda, S. and Yamamoto, K. (1999) Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation. Oncogene 18, 7002-9.
Tamir, A., Howard, J., Higgins, R. R., Li, Y. J., Berger, L., Zacksenhaus, E., Reis, M. and Ben-David, Y. (1999) Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol. Cell. Biol. 19, 4452-64.
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y. and Nakamura, Y. (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404, 42-9.
Tanuma, N., Nakamura, K. and Kikuchi, K. (1999) Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. Eur. J. Biochem. 259, 46-54.
Tao, W. and Levine, A. J. (1999) Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA 96, 3077-80.
Tassan, J. P., Schultz, S. J., Bartek, J. and Nigg, E. A. (1994) Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127, 467-78.
Taylor, W. R. and Stark, G. R. (2001) Regulation of the G2/M transition by p53. Oncogene 20, 1803-15.
Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-62.
Thornberry, N. A. and Lazebnik, Y. (1998) Caspases: enemies within. Science 281, 1312-6.
Thullberg, M., Bartkova, J., Khan, S., Hansen, K., Ronnstrand, L., Lukas, J., Strauss, M. and Bartek, J. (2000) Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. FEBS Lett. 470, 161-6.
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S. Y., Taya, Y., Prives, C. and Abraham, R. T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-7.
Unger, T., Juven-Gershon, T., Moallem, E., Berger, M., Vogt Sionov, R., Lozano, G., Oren, M. and Haupt, Y. (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18, 1805-14.
Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T. and Thompson, C. B. (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-37.
Vaux, D. L., Haecker, G. and Strasser, A. (1994) An evolutionary perspective on apoptosis. Cell 76, 777-9.
Venot, C., Maratrat, M., Dureuil, C., Conseiller, E., Bracco, L. and Debussche, L. (1998) The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17, 4668-79.
Vogelstein, B., Lane, D. and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-10.
Vousden, K. H. and Woude, G. F. (2000) The ins and outs of p53. Nat. Cell Biol. 2, E178-80.
Waga, S., Hannon, G. J., Beach, D. and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-8.
Walker, D. H. and Maller, J. L. (1991) Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature 354, 314-7.
Walker, K. K. and Levine, A. J. (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc .Natl. Acad. Sci. USA 93, 15335-40.
Wang, M. C., Liu, J. H. and Wang, F. F. (1997) Protein tyrosine phosphatase-dependent activation of beta-globin and delta-aminolevulinic acid synthase genes in the camptothecin-induced IW32 erythroleukemia cell differentiation. Mol. Pharmacol. 51, 558-66.
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R. and Harris, C. C. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sc. USA 91, 2230-4.
Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J. M., Wang, Z., Freidberg, E. C., Evans, M. K., Taffe, B. G. and et al. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10, 188-95.
Wang, Y., Reed, M., Wang, P., Stenger, J. E., Mayr, G., Anderson, M. E., Schwedes, J. F. and Tegtmeyer, P. (1993) p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7, 2575-86.
Watanabe, T., Kume, T. and Oishi, M. (1992) Alteration of phosphotyrosine-containing proteins at the early stage of erythroid differentiation of mouse erythroleukemia (MEL) cells. J. Biol. Chem. 267, 17116-20.
Waterman, M. J., Stavridi, E. S., Waterman, J. L. and Halazonetis, T. D. (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19, 175-8.
Waterman, M. J., Stavridi, E. S., Waterman, J. L. and Halazonetis, T. D. (1998 ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19, 175-8.
White, E. (1996) Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15.
Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G. and Youle, R. J. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-92.
Wu, G. S., Burns, T. F., McDonald, E. R., 3rd, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G. and el-Deiry, W. S. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17, 141-3.
Wyllie, A. (1998) Apoptosis. An endonuclease at last. Nature 391, 20-1.
Yaginuma, Y. and Westphal, H. (1992) Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res. 52, 4196-9.
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P. and Wang, X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-32.
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. and Vogelstein, B. (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-82.
Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619-28.
Zhang, P., Liegeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A. and Elledge, S. J. (1997) Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-8.
Zhang, P., Liegeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A. and Elledge, S. J. (1997) Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-8.
Zhang, Y., Fujita, N. and Tsuruo, T. (1999) Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 18, 1131-8.
Zhou, B. B., Li, H., Yuan, J. and Kirschner, M. W. (1998) Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. USA 95, 6785-90.
|